Satellos Bioscience (MSLE) EBITDA Yield: History & Chart

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T17:52:28.324Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:52:28.324Z.

Quote observation: 2026-10-06T17:37:02.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: -35,506,111.393599994
Quote market capitalization: 10,370,364
Total debt · period ending 2026-06-30: 0
Cash · period ending 2026-06-30: 7,384,128

FMP input reference: a92f25166a0617989281a7eefd332dc08894ee274fcedbd674fe1a92e2c9d78d

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

MSLE EBITDA Yield Metrics

EBITDA YIELD

N/A

MSLE Competitors' EBITDA Yield

MSLE

Satellos Bioscience Inc.

Current

Market Cap

$10.37M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GDTC

CytoMed Therapeutics Limited

vs MSLE

Market Cap

$10.41M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SNTI

Senti Biosciences, Inc.

vs MSLE

Market Cap

$10.30M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

VBIO

Valion Bio, Inc.

vs MSLE

Market Cap

$10.25M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TVRD

Tvardi Therapeutics, Inc.

vs MSLE

Market Cap

$10.60M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LFWD

Lifeward Ltd.

vs MSLE

Market Cap

$10.52M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PLRZ

Polyrizon Ltd.

vs MSLE

Market Cap

$10.58M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PLUR

Pluri Inc.

vs MSLE

Market Cap

$10.59M

EBITDA Yield

N/A

TTM Avg

0.09%

3Y Avg

0.09%

5Y Avg

0.09%

LSTA

Lisata Therapeutics, Inc.

vs MSLE

Market Cap

$10.65M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MDCX

Medicus Pharma Ltd. Common Stock

vs MSLE

Market Cap

$10.08M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Satellos Bioscience Inc. (MSLE)	$10.37M	N/A	N/A	N/A	N/A
CytoMed Therapeutics Limited (GDTC)vs ›	$10.41M	N/A	N/A	N/A	N/A
Senti Biosciences, Inc. (SNTI)vs ›	$10.30M	N/A	N/A	N/A	N/A
Valion Bio, Inc. (VBIO)vs ›	$10.25M	N/A	N/A	N/A	N/A
Tvardi Therapeutics, Inc. (TVRD)vs ›	$10.60M	N/A	N/A	N/A	N/A
Lifeward Ltd. (LFWD)vs ›	$10.52M	N/A	N/A	N/A	N/A
Polyrizon Ltd. (PLRZ)vs ›	$10.58M	N/A	N/A	N/A	N/A
Pluri Inc. (PLUR)vs ›	$10.59M	N/A	0.09%	0.09%	0.09%
Lisata Therapeutics, Inc. (LSTA)vs ›	$10.65M	N/A	N/A	N/A	N/A
Medicus Pharma Ltd. Common Stock (MDCX)vs ›	$10.08M	N/A	N/A	N/A	N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

MSLE EBITDA Yield Metrics

MSLE Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics